Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?

29.07.25 15:55 Uhr

Werte in diesem Artikel
Aktien

261,95 EUR 1,90 EUR 0,73%

Indizes

PKT PKT

44.461,3 PKT -171,7 PKT -0,38%

23.345,4 PKT 37,1 PKT 0,16%

21.129,7 PKT 31,4 PKT 0,15%

3.135,7 PKT 0,3 PKT 0,01%

6.362,9 PKT -8,0 PKT -0,12%

Amgen Inc. (AMGN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AMGN's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross."A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving averages being the 50-day and the 200-day, since bigger time periods tend to form stronger breakouts.A successful golden cross event has three stages. It first begins when a stock's price on the decline bottoms out. Then, its shorter moving average crosses above its longer moving average, triggering a positive trend reversal. The third and final phase occurs when the stock maintains its upward momentum.A golden cross contrasts with a death cross, another widely-followed chart pattern that suggests bearish momentum could be on the horizon.AMGN could be on the verge of a breakout after moving 7.9% higher over the last four weeks. Plus, the company is currently a #3 (Hold) on the Zacks Rank.Looking at AMGN's earnings expectations, investors will be even more convinced of the bullish uptrend. For the current quarter, there have been 6 changes higher compared to none lower over the past 60 days, and the Zacks Consensus Estimate has moved up as well.With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on AMGN for more gains in the near future.Higher. Faster. Sooner. Buy These Stocks NowA small number of stocks are primed for a breakout, and you have a chance to get in before they take off.At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.Download the report free now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amgen Inc. (AMGN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Amgen und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Amgen

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Amgen

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Amgen Inc.

Wer­bung

Analysen zu Amgen Inc.

DatumRatingAnalyst
28.04.2021Amgen buyGoldman Sachs Group Inc.
28.04.2021Amgen NeutralJP Morgan Chase & Co.
05.03.2021Amgen buyGoldman Sachs Group Inc.
05.03.2021Amgen NeutralJP Morgan Chase & Co.
23.12.2020Amgen Sector PerformRBC Capital Markets
DatumRatingAnalyst
28.04.2021Amgen buyGoldman Sachs Group Inc.
05.03.2021Amgen buyGoldman Sachs Group Inc.
15.03.2019Amgen OutperformBMO Capital Markets
17.01.2019Amgen buyGoldman Sachs Group Inc.
08.12.2018Amgen buyGoldman Sachs Group Inc.
DatumRatingAnalyst
28.04.2021Amgen NeutralJP Morgan Chase & Co.
05.03.2021Amgen NeutralJP Morgan Chase & Co.
23.12.2020Amgen Sector PerformRBC Capital Markets
29.07.2020Amgen NeutralJP Morgan Chase & Co.
25.01.2020Amgen NeutralJP Morgan Chase & Co.
DatumRatingAnalyst
15.11.2012Amgen verkaufenHamburger Sparkasse AG (Haspa)
31.07.2012Amgen verkaufenHamburger Sparkasse AG (Haspa)
01.02.2012Amgen verkaufenHamburger Sparkasse AG (Haspa)
20.12.2011Amgen verkaufenHamburger Sparkasse AG (Haspa)
30.07.2008Amgen UpgradeIndependent Research GmbH

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Amgen Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen